Skip to main content
. Author manuscript; available in PMC: 2009 Sep 12.
Published in final edited form as: Life Sci. 2008 Jul 22;83(11-12):421–425. doi: 10.1016/j.lfs.2008.07.003

Fig. 1.

Fig. 1

Representative saturation binding analyses of 125I-SI-Ang II binding in the human cerebral cortical (rostral pole of the temporal lobe) membranes (obtained from the 9 h post mortem brains listed in Table 1) in the presence of 10 µM PD123319 and losartan in the absence or presence (indicated with “+”) of 0.3 mM PCMB. In “F+” Bmax=1.80±0.16 fmol/mg wet wt., and Kd=1.61±0.36 nM; “M+” Bmax=1.99±0.18 fmol/mg wet wt., and Kd=1.69±0.39 nM; in the absence of PCMB specific 125I-SI-Ang II binding was not significantly different from zero.